Binge Eating Disorder Pipeline Therapeutics Development Review H2 2015

Page 1

Binge Eating Disorder - Pipeline Review, H2 2015 Binge Eating Disorder - Pipeline Review, H2 2015 market research report is the latest addition to RnRMarketResearch.com and its collection of therapeutics business intelligence reports aimed to help take better decisions. This report provides comprehensive information on the therapeutic development for Binge Eating Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Binge Eating Disorder and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H2, 2015 Pipeline Review of “Binge Eating Disorder� addition with 22 market data tables and 10 figures, spread across 45 pages is http://www.rnrmarketresearch.com/binge-eating-disorder-pipeline-review-h2-2015market-report.html . This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Discussed/Mentioned in this Research: Eli Lilly and Company, Heptares Therapeutics Limited, Lightlake Therapeutics Inc., Omeros Corporation, Polleo Pharma Limited, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.